🌟 Photo Sharing Tips: How to Stand Out and Win?
1.Highlight Gate Elements: Include Gate logo, app screens, merchandise or event collab products.
2.Keep it Clear: Use bright, focused photos with simple backgrounds. Show Gate moments in daily life, travel, sports, etc.
3.Add Creative Flair: Creative shots, vlogs, hand-drawn art, or DIY works will stand out! Try a special [You and Gate] pose.
4.Share Your Story: Sincere captions about your memories, growth, or wishes with Gate add an extra touch and impress the judges.
5.Share on Multiple Platforms: Posting on Twitter (X) boosts your exposure an
BioSig commodity tokenization strategy
Key Points:* BioSig and Streamex merge to tokenize commodities on blockchain.
The initiative aims to introduce liquidity and transparency to the commodities market, impacting its $142 trillion value.
Funding and Institutional Backing in BioSig’s Commodity Shift
BioSig Technologies Inc., previously a medical technology company, has merged with Streamex to pivot towards blockchain tokenization of commodities. Led by CEO Henry McPhie, this endeavor includes securing up to $1.1 billion funding comprised of convertible bonds and equity facilities.
The merger seeks to integrate commodity trading onto blockchain platforms, notably enhancing liquidity and transparency. The initiative emphasizes gold-backed assets and targets a $142 trillion market landscape, marking a significant pivot for BioSig’s operations.
Blockchain Opportunity: BioSig Targets $142 Trillion Commodity Market
Did you know? BioSig’s move to tokenize commodities is reminiscent of earlier attempts like Pax Gold but is amplified by institutional backing and a $1.1 billion investment.
Solana (SOL) stands at $151.16 with a market cap of $80.96 billion, dominating 2.41% of the market. A trading volume of $3.77 billion reflects a 12.64% change. Over 90 days, Solana’s price rose by 41.89%, per CoinMarketCap data on July 8, 2025.
| | | --- | | DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |